Home » Topics » BioWorld Science

BioWorld Science
RSS

Biohaven establishes expanded access program for sublingual BHV-0223 for ALS

May 9, 2018

Atara Biotherapeutics expands collaboration with Memorial Sloan Kettering

May 9, 2018

Researchers present INT-1B3 as a promising antitumoral compound

May 9, 2018

Phase III TAGS trial of Lonsurf in metastatic gastric cancer meets primary endpoint

May 9, 2018

Alternative targeting of IDO pathway: New developments from the AAI annual meeting

May 9, 2018

Novo Nordisk reviews pipeline highlights of first quarter 2018

May 9, 2018

Janssen Pharma launches Sirturo Tablets in Japan

May 9, 2018

MG7-CART therapy evaluated for the first time in a patient with metastatic colorectal cancer

May 9, 2018

Provention Bio partners with Intravacc to advance CVB vaccine PRV-101

May 9, 2018

EMA approves Lynparza tablets for the treatment of platinum-sensitive relapsed ovarian cancer

May 9, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 15, 2026.
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...